Comparative pharmacokinetic evaluation of sustained-release theophylline formulations in dogs and humans
- 1 June 1987
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 37 (1-2) , 97-102
- https://doi.org/10.1016/0378-5173(87)90013-5
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Pharmacokinetic evaluation of novel sustained‐release dosage forms of valproic acid in humansBiopharmaceutics & Drug Disposition, 1985
- Comparative pharmacokinetic analysis of a novel sustained release dosage form of valproic acid in dogsBiopharmaceutics & Drug Disposition, 1984
- Effect of sustained release on the pharmacokinetics of valproic acid in the dogInternational Journal of Pharmaceutics, 1984
- A Clinical and Pharmacokinetic Basis for the Selection and Use of Slow Release Theophylline ProductsClinical Pharmacokinetics, 1984
- Bioavailability of Griseofulvin from Tablets in Beagle Dogs and Correlation with Dissolution Rate and Bioavailability in HumansJournal of Pharmaceutical Sciences, 1982
- Monitoring Serum Theophylline LevelsClinical Pharmacokinetics, 1978
- Pharmacokinetic analysis of the effect of the ophylline on pulmonary function in asthmatic childrenThe Journal of Pediatrics, 1975
- Pharmacokinetics of theophylline; Application to adjustment of the clinical dose of aminophyllineClinical Pharmacology & Therapeutics, 1972
- The Dog as a Quantitative Model for Evaluation of Nondisintegrating Sustained-Release TabletsJournal of Pharmaceutical Sciences, 1971
- In vivo Pharmacodynamic Evaluation of Oral Dosage Forms by Whole Body Liquid ScintillometryJournal of Pharmaceutical Sciences, 1966